IIVS | Assays Vaginal Irritation
95
archive,tax-assay,term-vaginal-irritation,term-95,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-,qode-theme-ver-11.0,qode-theme-bridge,wpb-js-composer js-comp-ver-4.11.2.1,vc_responsive

Archive

Collaborative Effort Aims to Replace Rabbit Test for Personal Lubricant Products

August 21, 2017
Study in Response to Consumer Demands for Humane Testing Washington, D.C. — August 21, 2017 — A first-of-its kind collaborative project is underway to find a non-animal test method to replace the rabbit vaginal irritation test for personal lubricants. The U.S. Food and Drug Administration (FDA) gave the project a green light as part of the agency’s program aimed at modernizing the tests used to develop and evaluate medical devices. The work of the lubricant industry, the Institute for In Vitro Sciences...

Webinar: How GLPs Enhance the Quality of Regulated and Non-Regulated Toxicology

October 18, 2016
This one-hour webinar, led by IIVS Director of Quality and Compliance, introduces some of the concepts of Good Laboratory Practices (GLPs) designed to promote study and data integrity within an in vitro toxicology framework. Applying these concepts within your own laboratory should aid in production of robust, repeatable studies. View Slides...

Vaginal Irritation

August 24, 2016
The irritation potential of pharmaceutical, cosmetic and personal care products that are specifically formulated for application onto human mucosal tissues is evaluated using reconstructed tissue models such as EpiVaginal™ (MatTek Corporation, Ashland, MA, USA) or the Human Vaginal Epithelium (HVE) (EpiSkin, Lyon, France). The toxicity is determined by measuring the relative viability of the tissues treated with the test materials and compared to the negative/solvent control-treated tissues. The safety of the pharmaceutical, cosmetic and personal care products that are specifically formulated...